Company Filing History:
Years Active: 2019-2025
Title: Christopher Vollmers: Innovator in Nucleic Acid Sequencing
Introduction
Christopher Vollmers is a prominent inventor based in Santa Cruz, California. He has made significant contributions to the field of nucleic acid sequencing, holding a total of 3 patents. His work focuses on developing advanced methods and technologies that enhance the efficiency and accuracy of nucleic acid analysis.
Latest Patents
Vollmers' latest patents include innovative methods for nucleic acid sequencing. One of his notable patents describes methods of nucleic acid sequencing that involve producing a circularized DNA, which includes a full-length cDNA and a known heterologous sequence. This process utilizes rolling circle amplification to create a concatemer that contains repeating segments of the full-length cDNA and the heterologous sequence. The methods also encompass obtaining raw sequencing reads using a nanopore, identifying the repeating segments, and generating a consensus sequence of the full-length cDNA based on these segments.
Another significant patent focuses on methods for producing nucleic acid libraries. This patent outlines techniques for creating tagged primer extension products and utilizing transposomes to generate tagged extension product fragments. The methods further include sequencing these products to determine the sequences of nucleic acids of interest. Compositions and kits for practicing these methods are also provided, showcasing the practical applications of his inventions.
Career Highlights
Christopher Vollmers is affiliated with the University of California, where he continues to advance research in nucleic acid technologies. His work has garnered attention for its potential to revolutionize the field of genomics and molecular biology.
Collaborations
Vollmers collaborates with esteemed colleagues, including Charles Cole and Roger Volden. Their combined expertise contributes to the innovative research and development of nucleic acid sequencing methods.
Conclusion
Christopher Vollmers is a key figure in the advancement of nucleic acid sequencing technologies. His patents reflect a commitment to innovation and excellence in the field, paving the way for future developments in genetic research.